<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17437" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Amebic Meningoencephalitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Pana</surname>
            <given-names>Angela</given-names>
          </name>
          <aff>Louisiana State University HSC</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Vijayan</surname>
            <given-names>Vini</given-names>
          </name>
          <aff>Valley Children's Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Anilkumar</surname>
            <given-names>Arayamparambil C.</given-names>
          </name>
          <aff>SUNY Upstate Medical University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Angela Pana declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vini Vijayan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Arayamparambil Anilkumar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>21</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17437.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Amebic encephalitis is a rare but lethal central nervous system infection caused by free-living amoebae found in freshwater, lakes, and rivers. There are 2 types of amebic encephalitis, namely primary meningoencephalitis and granulomatous amebic encephalitis (GAE). The initial symptoms of PAM are indistinguishable from bacterial meningitis, while the symptoms of GAE can mimic a brain abscess, encephalitis, or meningitis. These infections are almost uniformly fatal. The mortality rate is above 90%, despite antimicrobial therapy. This activity discusses the role of the interprofessional team, describes the causative agent of amebic meningoencephalitis, its pathophysiology, the clinical presentation, and highlights measures of prevention.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the causative agents of amebic encephalitis.</p></list-item><list-item><p>Describe the clinical presentation of amebic encephalitis and plan the diagnostic evaluation and treatment.</p></list-item><list-item><p>Summarize the treatment and management options available for amebic encephalitis.</p></list-item><list-item><p>Outline the measures to prevent the disease and the treatment by the interprofessional team that will decrease the number of cases and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17437&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17437">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17437.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Free-living amebas are protozoan environmental parasites, mainly in freshwater, lakes, and rivers, without needing a definitive host.<xref ref-type="bibr" rid="article-17437.r1">[1]</xref> In humans, there are four main genera of amebas that can cause disease, namely&#x000a0;<italic toggle="yes">Naegleria</italic>&#x000a0;(only&#x000a0;<italic toggle="yes">Naegleria fowleri)</italic>,&#x000a0;<italic toggle="yes">Acanthamoeba</italic>&#x000a0;(several species),&#x000a0;<italic toggle="yes">Sappinia</italic> (only S<italic toggle="yes">&#x000a0;pedata</italic>), and&#x000a0;<italic toggle="yes">Balamuthia&#x000a0;</italic>(only&#x000a0;<italic toggle="yes">Balamuthia mandrillaris</italic>)<italic toggle="yes">.</italic><xref ref-type="bibr" rid="article-17437.r2">[2]</xref> The amebas have a propensity to cause central nervous system (CNS) infections, but Acanthamoeba is well-known to cause keratitis and disseminated infections as well.<xref ref-type="bibr" rid="article-17437.r1">[1]</xref><xref ref-type="bibr" rid="article-17437.r3">[3]</xref></p>
        <p>These free-living amebas can cause 2 distinct clinical syndromes, primary amebic meningoencephalitis (PAM) and granulomatous amebic encephalitis (GAE). The initial symptoms of PAM are indistinguishable from bacterial meningitis, while the symptoms of GAE can mimic a brain abscess, encephalitis, or meningitis. These infections are almost uniformly&#x000a0;fatal. The mortality rate is above 90%, despite antimicrobial therapy.<xref ref-type="bibr" rid="article-17437.r4">[4]</xref></p>
      </sec>
      <sec id="article-17437.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>PAM is caused by <italic toggle="yes">Naegleria fowleri,</italic>&#x000a0;a thermophilic, free-living ameba that lives in temperatures above 30 &#x000b0;C and can tolerate temperatures up to 45 &#x000b0;C.&#x000a0;This protozoan parasite is found in the soil and freshwaters, such as ponds, lakes, rivers, streams, hot springs, and unchlorinated swimming pools. Risk factors for infection include swimming, diving, waterskiing, surfing, and exposure to hot springs. The use of tap water for nasal irrigation has also been reported as a risk factor for the disease.<xref ref-type="bibr" rid="article-17437.r1">[1]</xref><xref ref-type="bibr" rid="article-17437.r3">[3]</xref>&#x000a0;GAE is a subacute to chronic infection of the CNS caused by&#x000a0;<italic toggle="yes">Acanthamoeba</italic>&#x000a0;species such as <italic toggle="yes">A.culbertsoni, A polyphagia, A castellani, A astronyxis, A hatchetti, A rhysodes, A divionensis, A lugdunensis, A lenticulata,</italic> and <italic toggle="yes">A haely, and</italic>
<italic toggle="yes">B mandrillaris</italic>. <italic toggle="yes">Acanthamoeba</italic>&#x000a0;is found in soil as well as brackish water, sewage, and humidifiers.<xref ref-type="bibr" rid="article-17437.r1">[1]</xref><xref ref-type="bibr" rid="article-17437.r3">[3]</xref></p>
      </sec>
      <sec id="article-17437.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>PAM and GAE are very rare disease processes, with only 3.7 cases reported per year worldwide. PAM is more common in warmer regions, such as the southern part of the United States, and generally occurs in the&#x000a0;warmer months of spring and summer, possibly due to the increased likelihood of participation in waterborne activities. The mean age of patients affected by PAM was 12 years (ranging from 8 months&#x000a0;to 66 years); 79% were males.<xref ref-type="bibr" rid="article-17437.r5">[5]</xref><xref ref-type="bibr" rid="article-17437.r6">[6]</xref><xref ref-type="bibr" rid="article-17437.r7">[7]</xref><xref ref-type="bibr" rid="article-17437.r8">[8]</xref></p>
      </sec>
      <sec id="article-17437.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>PAM occurs in healthy young individuals exposed to warm freshwater.&#x000a0;<italic toggle="yes">Naegleria fowleri</italic>&#x000a0;infects susceptible individuals when contaminated water enters the body through the nose. Trophozoites penetrate the olfactory mucosa, cross the cribriform plates, and ultimately reach the olfactory bulb and cause the&#x000a0;inflammatory reaction and the parenchymal damage associated with PAM.<xref ref-type="bibr" rid="article-17437.r7">[7]</xref>&#x000a0;GAE occurs when the infective form of Acanthamoeba, the trophozoites, enters the body through the eyes, nasal passages, and respiratory tract or ulcerated skin. Once it gains entry, the parasite invades the central nervous system by hematogenous dissemination resulting in GAE. Once in the central nervous system, the parasite stimulates abscess and focal granuloma formation. Disseminated disease, skin disease, and keratitis can also occur.<xref ref-type="bibr" rid="article-17437.r9">[9]</xref></p>
      </sec>
      <sec id="article-17437.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p><italic toggle="yes">Naegleria fowleri</italic>&#x000a0;has a 3 stage life cycle: amoeboid trophozoites, flagellate, and cysts. Hostile environmental changes can cause the trophozoites to change to the flagellated form, and the parasite will revert when conditions improve. <italic toggle="yes">Naegleria fowleri</italic>&#x000a0;trophozoites are found in cerebrospinal fluid (CSF) and tissue, and occasionally, flagellated forms may be noted in the CSF. Cysts are not seen in brain tissue.<xref ref-type="bibr" rid="article-17437.r1">[1]</xref><xref ref-type="bibr" rid="article-17437.r3">[3]</xref>&#x000a0;On the contrary, <italic toggle="yes">Acanthamoeba</italic>&#x000a0;exists in only two forms, cysts and trophozoites. The trophozoites are the infective forms. Both <italic toggle="yes">Acanthamoeba</italic>&#x000a0;spp. cysts and trophozoites are found in tissue.<xref ref-type="bibr" rid="article-17437.r3">[3]</xref></p>
      </sec>
      <sec id="article-17437.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with PAM typically present acutely with fever, severe headache, photophobia, nausea, vomiting, behavioral abnormalities, seizures, and altered mental status. A history of olfactory and taste abnormalities is frequently associated with PAM. Patients with PAM&#x000a0;typically have a history of swimming, diving, bathing, or playing in warm, generally stagnant freshwater during the previous 1&#x000a0;through 9 days. On physical examination, meningismus and cranial nerve palsies can be seen.<xref ref-type="bibr" rid="article-17437.r10">[10]</xref> The disease progresses rapidly with increased intracranial pressure leading to uncal herniation and death.<xref ref-type="bibr" rid="article-17437.r8">[8]</xref></p>
        <p>The clinical presentation of GAE differs from that of PAM considerably. GAE presents as a subacute to chronic disease process with weeks to months of progressive headache, low-grade fevers, visual disturbances, behavioral abnormalities, and focal neurologic deficits. Ultimately, the patient develops increased intracranial pressure, seizures, coma, and death.<xref ref-type="bibr" rid="article-17437.r8">[8]</xref>&#x000a0;Among patients with human immunodeficiency virus, focal neurologic lesions mimicking toxoplasma encephalitis have also been reported.<xref ref-type="bibr" rid="article-17437.r11">[11]</xref></p>
      </sec>
      <sec id="article-17437.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Lumbar puncture for CSF analysis is the primary diagnostic tool for PAM, whereas tissue diagnosis is essential for GAE. Unfortunately, amebic meningoencephalitis is very rarely diagnosed before autopsy. Laboratory findings suggestive of PAM include leukocytosis with a left shift. The CSF opening pressure is very high. The CSF white cell count ranges from 300 to 26,000 cells/mm&#x000a0;with polymorphonuclear predominance. CSF red blood cells are usually seen, and hemorrhagic fluid is seen as the disease progresses. Hypoglycorrhachia and elevated protein are characteristic. A definitive diagnosis is made by observation of motile trophozoites on centrifuged CSF wet mount preparation. Giemsa or trichrome stains help in identifying morphologic features of the trophozoites<italic toggle="yes">.&#x000a0;</italic>The diagnosis can also be made by using laboratory testing for<italic toggle="yes"> Naegleria fowleri</italic>&#x000a0;nucleic acid in CSF, biopsy, or tissue specimens or <italic toggle="yes">Naegleria fowleri</italic>&#x000a0;antigen in CSF, biopsy, or tissue specimens.</p>
        <p>To establish the diagnosis of GAE, brain tissue demonstrating trophozoites and cysts is needed. Moderate granulomatous inflammation with prominent vascular involvement is typically present on brain biopsy. CSF parameters show mild pleocytosis with lymphocytic predominance, high protein concentration, and low or normal glucose concentration. Rarely,<italic toggle="yes"> Acanthamoeba</italic>&#x000a0;trophozoites may be seen on the Giemsa stain of the CSF sediment. Head computed tomography scanning or magnetic resonance imaging (MRI) should precede lumbar puncture if clinical signs of focal central nervous system involvement or elevated intracranial pressure are present. MRI of the brain shows the presence of single or multiple space-occupying lesions with ring enhancement. Computed tomography may show progressive hydrocephalus, meningeal thickening, pseudotumoral lesions, largely isolated lesions, or multifocal ring-enhancing lesions. On post-mortem examination, significant edema and hemorrhage of the brain are seen.<xref ref-type="bibr" rid="article-17437.r12">[12]</xref><xref ref-type="bibr" rid="article-17437.r13">[13]</xref><xref ref-type="bibr" rid="article-17437.r14">[14]</xref></p>
      </sec>
      <sec id="article-17437.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Due to the rarity of the disease and lack of clinical trials, the definitive treatment for GAE is not clear at this time. A combination of drugs is used. The Centers for Disease Control and Prevention recommend combination treatment with pentamidine, sulfadiazine, flucytosine, and either fluconazole or itraconazole. Multiple other regimens are also recommended. Chronic Acanthamoeba meningitis was successfully treated in 2 children with a combination of oral trimethoprim/sulfamethoxazole, rifampin, and ketoconazole.&#x000a0;Resection of brain lesions may help as well.<xref ref-type="bibr" rid="article-17437.r12">[12]</xref><xref ref-type="bibr" rid="article-17437.r13">[13]</xref><xref ref-type="bibr" rid="article-17437.r14">[14]</xref></p>
        <p>Similarly, the optimal treatment of PAM is unknown; reports range from 9 to 30 days.&#x000a0;For the treatment of PAM amphotericin B, both intravenously and intrathecally is recommended, but considering the fulminant course of the disease and high mortality rates, a combination of drugs is generally used. Reports include the use of amphotericin in addition to rifampin, fluconazole, miltefosine, and azithromycin. Posaconazole has also been shown to be effective in mouse models of disease. It may&#x000a0;replace fluconazole as the azole of choice, although further studies are warranted to confirm this choice.<xref ref-type="bibr" rid="article-17437.r12">[12]</xref><xref ref-type="bibr" rid="article-17437.r13">[13]</xref><xref ref-type="bibr" rid="article-17437.r14">[14]</xref></p>
        <p>Only one case of GAE due to <italic toggle="yes">Sappinia </italic>has been reported in humans (attributed to <italic toggle="yes">S diploidea</italic>).<xref ref-type="bibr" rid="article-17437.r15">[15]</xref> The patient was a previously healthy male farmer who engaged in handling livestock. The disease manifested as headache, vomiting, blurry vision, and loss of consciousness following a sinus infection. Histopathology of a single 2 cm focal lesion in the posterior left temporal lobe demonstrated trophozoites (40 to 60 microns in diameter) with two nuclei. The infection was likely acquired by inhalation. He&#x000a0;was treated with a combination of flucytosine (2.75 g, 4 times a day for 25 weeks),&#x000a0;itraconazole&#x000a0;(200 mg/day), intravenous pentamidine&#x000a0;isethionate (300 mg/day for 6 weeks),&#x000a0;and azithromycin (250 mg/day for 31 weeks). The treatment resulted in complete recovery.</p>
      </sec>
      <sec id="article-17437.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The clinical presentation of PAM is very similar to acute bacterial meningitis, and CSF parameters are also alike. Therefore, obtaining an epidemiological history in patients with suspected bacterial meningitis but negative cultures and failure to improve cannot be emphasized enough.<xref ref-type="bibr" rid="article-17437.r8">[8]</xref>&#x000a0;The differential diagnosis of GAE includes bacterial brain abscesses, tuberculosis, Nocardia, CNS aspergillosis, cryptococcosis, and <italic toggle="yes">Histoplasma</italic>. Toxoplasmosis and cysticercosis, as well as CNS lymphoma, should be considered.<xref ref-type="bibr" rid="article-17437.r8">[8]</xref></p>
      </sec>
      <sec id="article-17437.s11" sec-type="Treatment Planning ">
        <title>Treatment Planning </title>
        <table-wrap id="article-17437.table0" position="float" orientation="portrait">
          <caption>
            <title>Table 1. Drugs for primary amebic meningoencephalitis</title>
          </caption>
          <table style="height: 479px;" border="1" cellspacing="1" cellpadding="20">
            <tbody>
              <tr>
                <td style="width: 381.956543px;" rowspan="1" colspan="1">
<p><bold>Drug</bold></p>
</td>
                <td style="width: 643.858704px;" rowspan="1" colspan="1">
<bold>Dosage</bold>
</td>
              </tr>
              <tr>
                <td style="width: 381.956543px;" rowspan="1" colspan="1">
<p>Conventional amphotericin B</p>
</td>
                <td style="width: 643.858704px;" rowspan="1" colspan="1">1.5 mg/kg/day intravenously (IV) +/- intrathecally</td>
              </tr>
              <tr>
                <td style="width: 381.956543px;" rowspan="1" colspan="1">
<p>Rifampin</p>
</td>
                <td style="width: 643.858704px;" rowspan="1" colspan="1">Rifampicin; 10 mg/kg/day orally in 3 divided doses or every 24 hours</td>
              </tr>
              <tr>
                <td style="width: 381.956543px;" rowspan="1" colspan="1">
<p>Fluconazole (10 mg/kg/day IV or orally)</p>
</td>
                <td style="width: 643.858704px;" rowspan="1" colspan="1">10 mg/kg/day IV or orally</td>
              </tr>
              <tr>
                <td style="width: 381.956543px;" rowspan="1" colspan="1">
<p>Miltefosine</p>
</td>
                <td style="width: 643.858704px;" rowspan="1" colspan="1">
<p>45 kg: 50 mg orally twice daily</p>
<p>&#x02265;45 kg: 50 mg orally three times daily</p>
</td>
              </tr>
              <tr>
                <td style="width: 381.956543px;" rowspan="1" colspan="1">Azithromycin</td>
                <td style="width: 643.858704px;" rowspan="1" colspan="1">500 mg IV or orally&#x000a0;</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="article-17437.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>PAM is associated with an extremely high mortality rate. Studies have reported a case-fatality rate of as high as 99%. The mean time from onset of symptoms to death was 5.3 days (ranging from 1&#x000a0;to 12 days), and the mean time from exposure to death was 9.9 days (ranging from 6&#x000a0;to 17 days).</p>
      </sec>
      <sec id="article-17437.s13" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of PAM can include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hallucinations</p>
          </list-item>
          <list-item>
            <p>Seizures</p>
          </list-item>
          <list-item>
            <p>Comma</p>
          </list-item>
          <list-item>
            <p>Death</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17437.s14" sec-type="Consultations">
        <title>Consultations</title>
        <p>The patient is managed by emergency physicians, internists, and infectious disease consultants.</p>
      </sec>
      <sec id="article-17437.s15" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Measures to&#x000a0;prevent primary amebic meningoencephalitis due to&#x000a0;<italic toggle="yes">Naegleria</italic>&#x000a0;include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Avoid diving and jumping into stagnant freshwater.</p>
          </list-item>
          <list-item>
            <p>Consider using nose plugs for unavoidable exposures or pinching your nose shut when diving or swimming in freshwater.</p>
          </list-item>
          <list-item>
            <p>Keep your head above water when swimming in freshwater, hot springs, and other untreated thermal bodies of water.</p>
          </list-item>
          <list-item>
            <p>When participating in water-related activities, avoid digging, or stirring up the sediment.</p>
          </list-item>
          <list-item>
            <p>Use boiled, filtered, or sterile water for nasal or sinus irrigation, not tap water.&#x000a0;</p>
          </list-item>
        </list>
        <p>Measures to prevent GAE and keratitis due to&#x000a0;<italic toggle="yes">Acanthamoeba</italic>&#x000a0;include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Replace contacts as prescribed.</p>
          </list-item>
          <list-item>
            <p>Remove lenses before activity involving contact with water.</p>
          </list-item>
          <list-item>
            <p>Wash hands with soap before handling contact lenses and clean lenses as instructed by the manufacturer.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17437.s16" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Other important information to note includes the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Patients with PAM&#x000a0;typically have a history of swimming, diving, bathing, or playing in warm, generally stagnant freshwater during the previous 1&#x000a0;to 9 days.</p>
          </list-item>
          <list-item>
            <p>GAE presents as a subacute to chronic disease process with weeks to months of progressive headache, low-grade fevers, visual disturbances, behavioral abnormalities, and focal neurologic deficits.</p>
          </list-item>
          <list-item>
            <p>Two patterns of clinical presentation have been described with <italic toggle="yes">Balamuthia mandrillaris.</italic>&#x000a0;While some patients present with an initial skin lesion followed by neurologic manifestations in weeks or months, others present with CNS involvement. The skin lesion consists of an asymptomatic nonulcerated plaque, most commonly on the central face or&#x000a0;the knee area. Wide resection of the skin may prove to be therapeutic.</p>
          </list-item>
          <list-item>
            <p>A definitive diagnosis of PAM is made by observation of motile trophozoites on centrifuged CSF wet mount preparation.</p>
          </list-item>
          <list-item>
            <p>Approximately 11 survivors of PAM have been reported in the literature.<xref ref-type="bibr" rid="article-17437.r16">[16]</xref><xref ref-type="bibr" rid="article-17437.r17">[17]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17437.s17" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Amebic encephalitis is an exceptionally rare and highly lethal&#x000a0;central nervous system infection caused by free-living amoebae found in freshwater, lakes, and rivers. There are two types of amebic encephalitis: primary amebic meningoencephalitis and granulomatous amebic encephalitis. The initial symptoms of PAM are indistinguishable from bacterial&#x000a0;meningitis,&#x000a0;while the symptoms of GAM can mimic a brain abscess or meningitis. These infections are almost always fatal. The high mortality rate is&#x000a0;due to a lack of optimal treatment, the rarity of the disease, and delays in diagnosis. Clinicians working in communities with potential exposure to large stagnant bodies of freshwater should play a role in educating patients about the risk and providing information about how to mitigate the risk. If the disease is being considered in the differential diagnosis of a patient, early laboratory evaluation and emergent consultations with infectious disease specialists, neurologists, and neurosurgeons&#x000a0;are recommended to facilitate prompt diagnosis and treatment.&#x000a0;</p>
        <p>Patients with amebic meningoencephalitis may require monitoring in the intensive care unit. A hypothermia protocol may be considered as this has been shown to increase survival.&#x000a0;An interprofessional healthcare team, including intensivists, infectious disease specialists, nurses, social workers, and pharmacists (specialized in infectious disease), may help facilitate family support and provide updates regarding the condition and prognosis of the patient. Intensive care nurses monitor patients and notify the team of status changes. The few reported survivors have been left with severe neurological disabilities and sequelae of encephalitis. Infectious disease pharmacists review treatment protocols, assess microbial susceptibility to the regimen chosen, and check for drug-drug interactions, reporting their findings to the prescribing/ordering clinician. This interprofessional model will&#x000a0;increase the odds of improved patient outcomes, despite the bleak prognosis.&#x000a0;</p>
      </sec>
      <sec id="article-17437.s18">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17437&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17437">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/amebic-meningoencephalitis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=17437">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17437/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17437">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-17437.s19">
        <title>References</title>
        <ref id="article-17437.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schuster</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Visvesvara</surname>
                <given-names>GS</given-names>
              </name>
            </person-group>
            <article-title>Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals.</article-title>
            <source>Int J Parasitol</source>
            <year>2004</year>
            <month>Aug</month>
            <volume>34</volume>
            <issue>9</issue>
            <fpage>1001</fpage>
            <page-range>1001-27</page-range>
            <pub-id pub-id-type="pmid">15313128</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17437.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Qvarnstrom</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>da Silva</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Schuster</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Gelman</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Visvesvara</surname>
                <given-names>GS</given-names>
              </name>
            </person-group>
            <article-title>Molecular confirmation of Sappinia pedata as a causative agent of amoebic encephalitis.</article-title>
            <source>J Infect Dis</source>
            <year>2009</year>
            <month>Apr</month>
            <day>15</day>
            <volume>199</volume>
            <issue>8</issue>
            <fpage>1139</fpage>
            <page-range>1139-42</page-range>
            <pub-id pub-id-type="pmid">19302010</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17437.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Visvesvara</surname>
                <given-names>GS</given-names>
              </name>
            </person-group>
            <article-title>Infections with free-living amebae.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2013</year>
            <volume>114</volume>
            <fpage>153</fpage>
            <page-range>153-68</page-range>
            <pub-id pub-id-type="pmid">23829906</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17437.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ma</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Visvesvara</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Martinez</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Theodore</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Daggett</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Sawyer</surname>
                <given-names>TK</given-names>
              </name>
            </person-group>
            <article-title>Naegleria and Acanthamoeba infections: review.</article-title>
            <source>Rev Infect Dis</source>
            <year>1990</year>
            <season>May-Jun</season>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>490</fpage>
            <page-range>490-513</page-range>
            <pub-id pub-id-type="pmid">2193354</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17437.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cope</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kahler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gorbett</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Corbitt</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Roy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Roellig</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Brewer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>VR</given-names>
              </name>
            </person-group>
            <article-title>Primary Amebic Meningoencephalitis Associated With Rafting on an Artificial Whitewater River: Case Report and Environmental Investigation.</article-title>
            <source>Clin Infect Dis</source>
            <year>2018</year>
            <month>Feb</month>
            <day>01</day>
            <volume>66</volume>
            <issue>4</issue>
            <fpage>548</fpage>
            <page-range>548-553</page-range>
            <pub-id pub-id-type="pmid">29401275</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17437.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maciver</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Pi&#x000f1;ero</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Lorenzo-Morales</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Is Naegleria fowleri an Emerging Parasite?</article-title>
            <source>Trends Parasitol</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>36</volume>
            <issue>1</issue>
            <fpage>19</fpage>
            <page-range>19-28</page-range>
            <pub-id pub-id-type="pmid">31744676</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17437.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Graciaa</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Cope</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Cikesh</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Kahler</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Vigar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hilborn</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Wade</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Backer</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Montgomery</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Secor</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>VR</given-names>
              </name>
              <name>
                <surname>Beach</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Fullerton</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Yoder</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Hlavsa</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Outbreaks Associated with Untreated Recreational Water - United States, 2000-2014.</article-title>
            <source>MMWR Morb Mortal Wkly Rep</source>
            <year>2018</year>
            <month>Jun</month>
            <day>29</day>
            <volume>67</volume>
            <issue>25</issue>
            <fpage>701</fpage>
            <page-range>701-706</page-range>
            <pub-id pub-id-type="pmid">29953425</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17437.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matanock</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mehal</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Blau</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Cope</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Estimation of Undiagnosed Naegleria fowleri Primary Amebic Meningoencephalitis, United States<sup>1</sup>.</article-title>
            <source>Emerg Infect Dis</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>162</fpage>
            <page-range>162-164</page-range>
            <pub-id pub-id-type="pmid">29260676</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17437.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dzikowiec</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>G&#x000f3;ralska</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>B&#x00142;aszkowska</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Neuroinvasions caused by parasites.</article-title>
            <source>Ann Parasitol</source>
            <year>2017</year>
            <volume>63</volume>
            <issue>4</issue>
            <fpage>243&#x02013;253</fpage>
            <pub-id pub-id-type="pmid">29385325</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17437.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Visvesvara</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Moura</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Schuster</surname>
                <given-names>FL</given-names>
              </name>
            </person-group>
            <article-title>Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea.</article-title>
            <source>FEMS Immunol Med Microbiol</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>50</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-26</page-range>
            <pub-id pub-id-type="pmid">17428307</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17437.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Damhorst</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Watts</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hernandez-Romieu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mel</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Palmore</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>IKM</given-names>
              </name>
              <name>
                <surname>Neill</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Kalapila</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cope</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Acanthamoeba castellanii encephalitis in a patient with AIDS: a case report and literature review.</article-title>
            <source>Lancet Infect Dis</source>
            <year>2022</year>
            <month>Feb</month>
            <volume>22</volume>
            <issue>2</issue>
            <fpage>e59</fpage>
            <page-range>e59-e65</page-range>
            <pub-id pub-id-type="pmid">34461057</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17437.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pugh</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Naegleria fowleri: Diagnosis, Pathophysiology of Brain Inflammation, and Antimicrobial Treatments.</article-title>
            <source>ACS Chem Neurosci</source>
            <year>2016</year>
            <month>Sep</month>
            <day>21</day>
            <volume>7</volume>
            <issue>9</issue>
            <fpage>1178</fpage>
            <page-range>1178-9</page-range>
            <pub-id pub-id-type="pmid">27525348</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17437.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Visvesvara</surname>
                <given-names>GS</given-names>
              </name>
            </person-group>
            <article-title>Amebic meningoencephalitides and keratitis: challenges in diagnosis and treatment.</article-title>
            <source>Curr Opin Infect Dis</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>23</volume>
            <issue>6</issue>
            <fpage>590</fpage>
            <page-range>590-4</page-range>
            <pub-id pub-id-type="pmid">20802332</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17437.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lopez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Budge</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bilyeu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mirza</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Custodio</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Irazuzta</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Visvesvara</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <article-title>Primary amebic meningoencephalitis: a case report and literature review.</article-title>
            <source>Pediatr Emerg Care</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>272</fpage>
            <page-range>272-6</page-range>
            <pub-id pub-id-type="pmid">22391923</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17437.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gelman</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Rauf</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Nader</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Popov</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Borkowski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chaljub</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nauta</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Visvesvara</surname>
                <given-names>GS</given-names>
              </name>
            </person-group>
            <article-title>Amoebic encephalitis due to Sappinia diploidea.</article-title>
            <source>JAMA</source>
            <year>2001</year>
            <month>May</month>
            <day>16</day>
            <volume>285</volume>
            <issue>19</issue>
            <fpage>2450</fpage>
            <page-range>2450-1</page-range>
            <pub-id pub-id-type="pmid">11368696</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17437.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shakoor</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Beg</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Mahmood</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Bandea</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sriram</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Noman</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Visvesvara</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Zafar</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Primary amebic meningoencephalitis caused by Naegleria fowleri, Karachi, Pakistan.</article-title>
            <source>Emerg Infect Dis</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>258</fpage>
            <page-range>258-61</page-range>
            <pub-id pub-id-type="pmid">21291600</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17437.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yadav</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Aneja</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dutta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Maheshwari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Seth</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Youngest survivor of naegleria meningitis.</article-title>
            <source>Indian J Pediatr</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>80</volume>
            <issue>3</issue>
            <fpage>253</fpage>
            <page-range>253-4</page-range>
            <pub-id pub-id-type="pmid">22544673</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
